Bolt Therapeutics, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Bolt Therapeutics, Inc. | BOLT - NASDAQ |
$18.00-$19.00 | $20.00 | $26.10 | 11.5 million | 2/5/2021 |
| Morgan Stanley, SVB Leerink, Stifel, Guggenheim Securities | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-01-15 Terms Added 2021-02-01 Amended Terms 2021-02-03 | ||||||
Bolt Therapeutics, Inc. Quote & Chart - Click for current quote - BOLT
IPO Boutique aggregates information on public companies and private companies, such as "BOLT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Bolt Therapeutics, Inc. (adapted from Bolt Therapeutics, Inc. prospectus):
They are a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "BOLT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.